HIV infection and hepatitis B seroprevalence among antenatal clinic attendees in Niger, West Africa

HIV infection and hepatitis B seroprevalence among antenatal clinic attendees in Niger, West Africa

Saïdou Mamadou1,2, Moussa Ide3, Amadou Roufaï Ali Maazou2, Balki Aoula2, Seyni Labo4, Mamane Bozari41Laboratory of Bacteriology-Virology, Faculty of Health Sciences, University Abdou Moumouni, Niamey, Niger; 2National Reference Laboratory for STI/HIV/TB, Niamey, Niger; 3Coo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mamadou S, Ide M, Maazou ARA, Aoula B, Labo S, Bozari M
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2011
Materias:
Immunologic diseases. Allergy
RC581-607
Acceso en línea:https://doaj.org/article/6e8f383d7b214444b8a6752762e3d572
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6e8f383d7b214444b8a6752762e3d572
record_format dspace
spelling oai:doaj.org-article:6e8f383d7b214444b8a6752762e3d5722021-12-02T01:15:32ZHIV infection and hepatitis B seroprevalence among antenatal clinic attendees in Niger, West Africa1179-1373https://doaj.org/article/6e8f383d7b214444b8a6752762e3d5722011-12-01T00:00:00Zhttp://www.dovepress.com/hiv-infection-and-hepatitis-b-seroprevalence-among-antenatal-clinic-at-a8929https://doaj.org/toc/1179-1373Saïdou Mamadou1,2, Moussa Ide3, Amadou Roufaï Ali Maazou2, Balki Aoula2, Seyni Labo4, Mamane Bozari41Laboratory of Bacteriology-Virology, Faculty of Health Sciences, University Abdou Moumouni, Niamey, Niger; 2National Reference Laboratory for STI/HIV/TB, Niamey, Niger; 3Coordination Board, Inter-Sectorial Program on STI/HIV/AIDS, Niamey, Niger; 4National Center for Social Sciences Expertise, Niamey, NigerAbstract: This transversal study was suggested in order to estimate the nationwide seroprevalences of HIV infection and hepatitis B among 495 pregnant women in Niger in 2008. The study detected anti-HIV antibodies with Genscreen® Plus HIV Ag/Ab Ultra Kit (Bio-Rad; Hercules, CA), Vironostika® HIV Uni-Form II Ag/Ab (bioMérieux; Marcy-l’Etoile, France), and ImmunoComb® II HIV 1 and 2 BiSpot (Orgenics; Yavne, Israel). HBsAg was detected by Monolisa® HBsAg Ultra (Bio-Rad) and ImmunoComb® II HBsAg (Orgenics). The rates obtained were 2.02% (95% confidence intervals (CI): 1.03%–3.81%) and 16.16% (95% CI: 13.09%–19.77%), respectively. There were no significant variations according to environment, region, age, marital status, educational level, antecedent of surgery and transfusion. But these data need a large sample, and periodic updates for a better planning of activities in the framework of a national reproductive health program, including prevention of mother-to-child HIV transmission.Keywords: HIV, HBV, seroprevalence, pregnant women, NigerMamadou SIde MMaazou ARAAoula BLabo SBozari MDove Medical PressarticleImmunologic diseases. AllergyRC581-607ENHIV/AIDS: Research and Palliative Care, Vol 2012, Iss default, Pp 1-4 (2011)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
spellingShingle Immunologic diseases. Allergy
RC581-607
Mamadou S
Ide M
Maazou ARA
Aoula B
Labo S
Bozari M
HIV infection and hepatitis B seroprevalence among antenatal clinic attendees in Niger, West Africa
description Saïdou Mamadou1,2, Moussa Ide3, Amadou Roufaï Ali Maazou2, Balki Aoula2, Seyni Labo4, Mamane Bozari41Laboratory of Bacteriology-Virology, Faculty of Health Sciences, University Abdou Moumouni, Niamey, Niger; 2National Reference Laboratory for STI/HIV/TB, Niamey, Niger; 3Coordination Board, Inter-Sectorial Program on STI/HIV/AIDS, Niamey, Niger; 4National Center for Social Sciences Expertise, Niamey, NigerAbstract: This transversal study was suggested in order to estimate the nationwide seroprevalences of HIV infection and hepatitis B among 495 pregnant women in Niger in 2008. The study detected anti-HIV antibodies with Genscreen® Plus HIV Ag/Ab Ultra Kit (Bio-Rad; Hercules, CA), Vironostika® HIV Uni-Form II Ag/Ab (bioMérieux; Marcy-l’Etoile, France), and ImmunoComb® II HIV 1 and 2 BiSpot (Orgenics; Yavne, Israel). HBsAg was detected by Monolisa® HBsAg Ultra (Bio-Rad) and ImmunoComb® II HBsAg (Orgenics). The rates obtained were 2.02% (95% confidence intervals (CI): 1.03%–3.81%) and 16.16% (95% CI: 13.09%–19.77%), respectively. There were no significant variations according to environment, region, age, marital status, educational level, antecedent of surgery and transfusion. But these data need a large sample, and periodic updates for a better planning of activities in the framework of a national reproductive health program, including prevention of mother-to-child HIV transmission.Keywords: HIV, HBV, seroprevalence, pregnant women, Niger
format article
author Mamadou S
Ide M
Maazou ARA
Aoula B
Labo S
Bozari M
author_facet Mamadou S
Ide M
Maazou ARA
Aoula B
Labo S
Bozari M
author_sort Mamadou S
title HIV infection and hepatitis B seroprevalence among antenatal clinic attendees in Niger, West Africa
title_short HIV infection and hepatitis B seroprevalence among antenatal clinic attendees in Niger, West Africa
title_full HIV infection and hepatitis B seroprevalence among antenatal clinic attendees in Niger, West Africa
title_fullStr HIV infection and hepatitis B seroprevalence among antenatal clinic attendees in Niger, West Africa
title_full_unstemmed HIV infection and hepatitis B seroprevalence among antenatal clinic attendees in Niger, West Africa
title_sort hiv infection and hepatitis b seroprevalence among antenatal clinic attendees in niger, west africa
publisher Dove Medical Press
publishDate 2011
url https://doaj.org/article/6e8f383d7b214444b8a6752762e3d572
work_keys_str_mv AT mamadous hivinfectionandhepatitisbseroprevalenceamongantenatalclinicattendeesinnigerwestafrica
AT idem hivinfectionandhepatitisbseroprevalenceamongantenatalclinicattendeesinnigerwestafrica
AT maazouara hivinfectionandhepatitisbseroprevalenceamongantenatalclinicattendeesinnigerwestafrica
AT aoulab hivinfectionandhepatitisbseroprevalenceamongantenatalclinicattendeesinnigerwestafrica
AT labos hivinfectionandhepatitisbseroprevalenceamongantenatalclinicattendeesinnigerwestafrica
AT bozarim hivinfectionandhepatitisbseroprevalenceamongantenatalclinicattendeesinnigerwestafrica
_version_ 1718403206880428032

Ejemplares similares